Transcriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatment
The greatest obstacle to a cure for HIV is the provirus that integrates into the genome of the infected cell and persists despite antiretroviral therapy. A “shock and kill” approach has been proposed as a strategy for an HIV cure whereby drugs and compounds referred to as latency-reversing agents (L...
| Główni autorzy: | , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Język: | English |
| Wydane: |
Frontiers Research Foundation
2018
|
| _version_ | 1826284548553441280 |
|---|---|
| author | White, C Beliakova-Bethell, N Lada, S Breen, M Hurst, T Spina, C Richman, D Frater, J Magiorkinis, G Woelk, C |
| author_facet | White, C Beliakova-Bethell, N Lada, S Breen, M Hurst, T Spina, C Richman, D Frater, J Magiorkinis, G Woelk, C |
| author_sort | White, C |
| collection | OXFORD |
| description | The greatest obstacle to a cure for HIV is the provirus that integrates into the genome of the infected cell and persists despite antiretroviral therapy. A “shock and kill” approach has been proposed as a strategy for an HIV cure whereby drugs and compounds referred to as latency-reversing agents (LRAs) are used to “shock” the silent provirus into active replication to permit “killing” by virus-induced pathology or immune recognition. The LRA most utilized to date in clinical trials has been the histone deacetylase (HDAC) inhibitor—vorinostat. Potentially, pathological off-target effects of vorinostat may result from the activation of human endogenous retroviruses (HERVs), which share common ancestry with exogenous retroviruses including HIV. To explore the effects of HDAC inhibition on HERV transcription, an unbiased pharmacogenomics approach (total RNA-Seq) was used to evaluate HERV expression following the exposure of primary CD4+ T cells to a high dose of vorinostat. Over 2,000 individual HERV elements were found to be significantly modulated by vorinostat, whereby elements belonging to the ERVL family (e.g., LTR16C and LTR33) were predominantly downregulated, in contrast to LTR12 elements of the HERV-9 family, which exhibited the greatest signal, with the upregulation of 140 distinct elements. The modulation of three different LTR12 elements by vorinostat was confirmed by droplet digital PCR along a dose–response curve. The monitoring of LTR12 expression during clinical trials with vorinostat may be indicated to assess the impact of this HERV on the human genome and host immunity. |
| first_indexed | 2024-03-07T01:15:29Z |
| format | Journal article |
| id | oxford-uuid:8e82dfee-ffe8-477f-8bf6-959f3fef0c81 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:15:29Z |
| publishDate | 2018 |
| publisher | Frontiers Research Foundation |
| record_format | dspace |
| spelling | oxford-uuid:8e82dfee-ffe8-477f-8bf6-959f3fef0c812022-03-26T22:58:18ZTranscriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatmentJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:8e82dfee-ffe8-477f-8bf6-959f3fef0c81EnglishSymplectic Elements at OxfordFrontiers Research Foundation2018White, CBeliakova-Bethell, NLada, SBreen, MHurst, TSpina, CRichman, DFrater, JMagiorkinis, GWoelk, CThe greatest obstacle to a cure for HIV is the provirus that integrates into the genome of the infected cell and persists despite antiretroviral therapy. A “shock and kill” approach has been proposed as a strategy for an HIV cure whereby drugs and compounds referred to as latency-reversing agents (LRAs) are used to “shock” the silent provirus into active replication to permit “killing” by virus-induced pathology or immune recognition. The LRA most utilized to date in clinical trials has been the histone deacetylase (HDAC) inhibitor—vorinostat. Potentially, pathological off-target effects of vorinostat may result from the activation of human endogenous retroviruses (HERVs), which share common ancestry with exogenous retroviruses including HIV. To explore the effects of HDAC inhibition on HERV transcription, an unbiased pharmacogenomics approach (total RNA-Seq) was used to evaluate HERV expression following the exposure of primary CD4+ T cells to a high dose of vorinostat. Over 2,000 individual HERV elements were found to be significantly modulated by vorinostat, whereby elements belonging to the ERVL family (e.g., LTR16C and LTR33) were predominantly downregulated, in contrast to LTR12 elements of the HERV-9 family, which exhibited the greatest signal, with the upregulation of 140 distinct elements. The modulation of three different LTR12 elements by vorinostat was confirmed by droplet digital PCR along a dose–response curve. The monitoring of LTR12 expression during clinical trials with vorinostat may be indicated to assess the impact of this HERV on the human genome and host immunity. |
| spellingShingle | White, C Beliakova-Bethell, N Lada, S Breen, M Hurst, T Spina, C Richman, D Frater, J Magiorkinis, G Woelk, C Transcriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatment |
| title | Transcriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatment |
| title_full | Transcriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatment |
| title_fullStr | Transcriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatment |
| title_full_unstemmed | Transcriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatment |
| title_short | Transcriptional modulation of human endogenous retroviruses in primary CD4+ T xells following vorinostat treatment |
| title_sort | transcriptional modulation of human endogenous retroviruses in primary cd4 t xells following vorinostat treatment |
| work_keys_str_mv | AT whitec transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment AT beliakovabethelln transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment AT ladas transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment AT breenm transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment AT hurstt transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment AT spinac transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment AT richmand transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment AT fraterj transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment AT magiorkinisg transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment AT woelkc transcriptionalmodulationofhumanendogenousretrovirusesinprimarycd4txellsfollowingvorinostattreatment |